Education
About Us
Working with TipRanks
Follow Us
NERISSA KREHER Insider Profile
4 Followers
NERISSA KREHER, Chief Medical Officer at Tectonic Therapeutic, holds 25.50K shares in Rezolute (Ticker: RZLT), holds 40.04K shares in Entrada Therapeutics Inc (Ticker: TRDA), holds 2.94K shares in Tectonic Therapeutic (Ticker: TECX).
NERISSA KREHER has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that NERISSA KREHER holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by NERISSA KREHER
NERISSA KREHER's Trading History
Tectonic Therapeutic
Oct 10, 2018
Chief Medical Officer
Uninformative Buy
2.68K
$68.20K
Rezolute
Feb 19, 2025
Director
Uninformative Buy
―
$98.17K
Entrada Therapeutics Inc
Sep 06, 2023
CMO
Uninformative Buy
―
$431.20K
List of latest transactions for each holding click on a transaction to see NERISSA KREHER's performance on stock
You May Also Like
NERISSA KREHER insider profile FAQ
What is the percentage of profitable transactions made by NERISSA KREHER?
The percentage of profitable transactions made by NERISSA KREHER is ―.
What is the average return per transaction made by NERISSA KREHER?
The average return per transaction made by NERISSA KREHER is ―.
What stocks does NERISSA KREHER hold?
NERISSA KREHER holds: TECX, RZLT, TRDA stocks.
What was NERISSA KREHER’s latest transaction?
NERISSA KREHER latest transaction was an Uninformative Buy of ―.
What was NERISSA KREHER's most profitable transaction?
NERISSA KREHER’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is NERISSA KREHER's role in Tectonic Therapeutic?
NERISSA KREHER's role in Tectonic Therapeutic is Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.